Sshekhar898 at 12:56, 30 December 2025

2025-12-30T12:56:19Z

New page

{{Short description|Indian pharmaceutical company}}
{{Use dmy dates|date=April 2024}}
{{Use Indian English|date=July 2018}}
{{Infobox company
| name = Hetero Drugs Limited
| logo = Hetero_Drugs_Logo.svg
| type = Private
| industry = [[Pharmaceuticals]]
| foundation = 1993
| founder = Dr. [[B. Parthasaradhi Reddy]]
| location = [[Hyderabad]], [[India]]
| key_people = Dr. B. Vamsi Krishna Reddy
| num_employees = Over 22,000
| homepage = {{official URL}}
}}
'''Hetero Drugs''' is an Indian [[pharmaceutical]] company and the world's largest producer of anti-retroviral drugs. Hetero's business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.

==Operations==
Hetero group employs over 22,000 people. Hetero is a participant in the [[active pharmaceutical ingredients]] market and finished dosages.<ref name="hep-c-news1">{{cite web |url=http://hep-c-news.com/hepatitis-c-treatment-in-india-for-less-than-1000/ |title=Hepatitis C treatment in India for less than $1000 | Hep C News - Hepatitis C Treatment, Cure Rate and Cost |access-date=2016-07-11 |url-status=dead |archive-url=https://web.archive.org/web/20160916124038/http://hep-c-news.com/blog/2016/07/11/hepatitis-c-treatment-in-india-for-less-than-1000/ |archive-date=2016-09-16 }}</ref> It has marketing presence in over 140 countries.

Hetero Group's subsidiaries include Hetero Drugs, Hetero Labs, Hetero Research Foundation, Genx Laboratories and also foreign subsidiaries such as Camber Pharmaceuticals in the [[United States]],<ref>{{cite news |last1=Walsh |first1=James D. |title=The Empty Adderall Factory |url=https://nymag.com/intelligencer/article/adderall-shortage-adhd-medication-ascent-pharmaceuticals.html |access-date=20 February 2024 |work=Intelligencer |date=19 February 2024}}</ref> Hetero Europe in [[Europe]], Amarox Pharma Global in [[Indonesia]], and Richmond Labs in [[Argentina]]. The group is also investing in the wind power industry with a goal to reach 1000 megawatts by 2017.<ref>{{cite web|url=http://www.heterowindpower.com/|title=Hetero Windpower|publisher=Hetero|access-date=22 June 2018}}</ref>

==2009 Swine flu outbreak==
In 2009, as the [[swine flu]] outbreak was spreading across the globe and various health organizations and government agencies were piling up stocks of Oseltamivir as precautionary measures, Hetero supplied generic Oseltamivir under its brand name [[Fluvir]].<ref>[http://www.thehindubusinessline.com/2009/04/29/stories/2009042952121500.htm Swine flu: Centre taps Hetero for generic Tamiflu supply]{{webarchive |url=https://web.archive.org/web/20090430031832/http://www.thehindubusinessline.com/2009/04/29/stories/2009042952121500.htm |date=30 April 2009 }}</ref>

Hetero delivered 10 million doses of Oseltamivir to the Indian government in 2009,<ref>{{cite web|author=Khomba Singh|url=http://economictimes.indiatimes.com/News-by-Industry/Hetero-bags-govts-anti-flu-drug-deal/articleshow/4484144.cms |title=Hetero bags mega chunk of govt's anti-flu drug deal |work=The Economic Times |date=2009-05-05 |access-date=2014-01-11}}</ref> and shipped about 80 million doses to over 60 countries.<ref>{{cite web|url=http://www.moneycontrol.com/india/news/cnbc-tv18-comments/hyderabad-pharma-cos-cashon-swine-flu-fever/411305 |title=Hyderabad pharma cos cash in on Swine-Flu fever |publisher=Moneycontrol.com |access-date=2014-01-11}}</ref> Hetero received its second order from Indian government to supply another 10 million doses of Oseltamivir later in 2009.<ref>{{cite web|author=Khomba Singh|url=http://economictimes.indiatimes.com/News/News-By-Industry/Healthcare-Biotech/Pharmaceuticals/Hetero-bags-deal-for-10-m-Tamiflu/articleshow/4921285.cms |title=Hetero bags deal for 10 m Tamiflu|work=The Economic Times |date=2009-08-22 |access-date=2014-01-11}}</ref>

==COVID-19 experimental drugs==
The company has launched the generic version of experimental [[COVID-19]] drug ''[[Remdesivir]]'' under brand name '''Covifor''' after acquiring license from [[Gilead Sciences]] and obtaining approval from [[Central Drugs Standard Control Organisation|CDSCO]], the Indian drug control authority.<ref>{{cite news |title=Covid-19: Hyderabad-based Hetero Labs Ltd prices generic version of remdesivir at Rs 5,400 per vial |url=https://indianexpress.com/article/cities/hyderabad/coronavirus-drug-remdesivir-generic-version-price-6475304/ |work=The Indian Express |date=25 June 2020}}</ref> On 29 July 2020, the company launched its version of the anti viral drug [[Favipiravir]] under the brand name Favivir, after getting approval from [[Drugs Controller General of India]] (DCGI), used in the treatment of mild to moderate [[COVID-19]] patients.<ref>{{Cite news|last=Kumar|first=N. Ravi|date=2020-07-29|title=India's Hetero Labs wins approval to sell COVID-19 drug favipiravir|work=The Hindu|url=https://www.thehindu.com/news/national/indias-hetero-labs-wins-approval-to-sell-covid-19-drug-favipiravir/article32218999.ece|access-date=2020-09-09|issn=0971-751X}}</ref> On 27 November 2020, Hetero Labs signed an agreement with the [[Russian Direct Investment Fund|Russian Direct Investment Fund (RDIF)]] to manufacture 100 million doses of the [[Gam-COVID-Vac|Sputnik V vaccine]].<ref>{{Cite news|last=Das|first=Sohini|date=2020-11-27|title=Hetero Labs to manufacture 100 mn doses of Sputnik V vaccine for India|work=Business Standard India|url=https://www.business-standard.com/article/companies/hetero-labs-to-manufacture-100-mn-doses-of-sputnik-v-vaccine-for-india-120112700495_1.html|access-date=2020-11-28}}</ref>

==References==
{{Reflist}}

{{Authority control}}

[[Category:Pharmaceutical companies of India]]
[[Category:Manufacturing companies based in Hyderabad, India]]
[[Category:Pharmaceutical companies established in 1993]]
[[Category:1993 establishments in Andhra Pradesh]]

Hetero Drugs - Revision history

Sshekhar898 at 12:56, 30 December 2025